Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,760 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07508124RecruitingPhase 4
Steroid cream to prevent repeat UTIs in uncircumcised baby boys
This study tests if a steroid cream applied to the foreskin can help prevent another urinary tract infection (UTI) in uncircumcised baby boys under 6 months old who have already had one confirmed UTI.
Houston, TexasAges birth–5 months - NCT06775496Recruiting
Study of life-threatening infections to find genetic causes
This trial studies people who have had a life-threatening infection to look for genetic reasons why some infections are so severe. If you or a child had a serious infection—like severe flu, meningitis, or a deep abscess—that could not be explained by a weak immune system from other causes, this study may help find answers.
Bologna, BolognaAges Any age - NCT05369052RecruitingPhase 3
New antibiotic for moderate or severe diabetic foot infections
This Phase 3 trial tests a new medicine (contezolid acefosamil, and contezolid) to treat moderate or severe diabetic foot infections. It compares the new treatment to linezolid to see which works better and is safer for adults.
Corona, CaliforniaAges 18 years+ - NCT04713670RecruitingPhase 4
Tested medicines to cure new H. pylori infection
This trial compares different stomach-medicine combinations to eliminate a new (first-time) H. pylori infection. It may help find the most effective treatment approach for people who have never tried eradication therapy before.
TaipeiAges 20 years+ - NCT04474132Recruiting
Testing for current or past Toxoplasmosis infection
This study checks whether a simple “point-of-care” test can detect current or past Toxoplasmosis infection (a common germ). Your results may help evaluate how well the test works and how it could be used in care.
Chicago, IllinoisAges 18–90 - NCT04332848RecruitingPhase 4
Testing-guided treatment for stubborn stomach H. pylori
This trial studies whether using lab testing to guide antibiotic choice works better than using a standard (empirical) treatment plan for stubborn H. pylori infection. You might benefit if past treatments have not cleared the infection after multiple attempts.
TaipeiAges 20–90 - NCT06887036RecruitingPhase 2
Methylene blue for chronic inactive hepatitis B
This trial tests whether a medication called methylene blue can help lower the amount of hepatitis B virus in people with a chronic but inactive infection. It may be an option for people whose virus levels are stable but not fully controlled.
Lugano, Canton TicinoAges 18–79 - NCT06775405RecruitingPhase 3
Testing a new RSV treatment for hospitalized babies
This study tests a medicine called AK0529 for babies and toddlers hospitalized with RSV. It aims to see if the drug helps them recover faster and is safe for this age group.
BeijingAges 1 month–2 years - NCT06794541RecruitingPhase 2
Testing eravacycline for kids with serious belly infections
This trial tests an antibiotic called eravacycline for children (ages 8–17) with serious belly infections. The medicine is given through an IV in the hospital to see if it is safe and tolerable.
Los Angeles, CaliforniaAges 8–17 - NCT06670885Enrolling by invitation
New DNA test for joint replacement infections
This trial uses advanced molecular methods to better diagnose infections in hip or knee replacement joints. The goal is to find infections more accurately so you can get the right treatment sooner.
Milan, MilanoAges 18 years+ - NCT06654154Recruiting
Vitamin B12 as a marker for disease activity in tocilizumab patients
This study looks at whether vitamin B12 levels in the blood can help tell if your disease is active or if you have an infection while being treated with tocilizumab. The goal is to find a simple way to monitor your condition without extra invasive tests.
Clermont-FerrandAges 18 years+ - NCT06579365Recruiting
Registry on H. pylori Infection Management in Argentina
This registry study tracks how H. pylori infection is managed in Argentina. It aims to collect real-world data to improve treatment for this common stomach infection.
Ciudad de Buenos AiresAges 18 years+ - NCT06546111RecruitingPhase 1/Phase 2
Diosmin and hesperidin for H. pylori infection
This trial tests whether a combination of two natural plant compounds, diosmin and hesperidin, can safely and effectively treat Helicobacter pylori (H. pylori) infection in people who have not been treated for it before. The goal is to see if this therapy offers a new option for clearing the bacteria.
Shibīn al KawmAges 18–75 - NCT06458231Recruiting
Measuring central line infection rates in sepsis patients
This study is about finding how common bloodstream infections are in people with central lines (a special IV for long-term medicines). It will help doctors learn how to prevent these infections.
Port SaidAges 1 day+ - NCT06203132RecruitingPhase 3
Doravirine vs Dolutegravir for first-time HIV treatment
This study compares two HIV medicines, doravirine and dolutegravir, to see which works better for people who have never taken HIV treatment before. If you qualify, you would be randomly assigned to one of the two medications.
Nova Iguaçu, Rio de JaneiroAges 18 years+ - NCT05871476Recruiting
Study to reduce resistant bacteria spread in young children
This study tests ways to reduce how a hard-to-treat bacterial germ spreads between hospitals, homes, communities, and animals. It focuses on children under 2 years old in the selected hospital area because they may be more likely to pick up and spread the bacteria.
Thái Bình, Thai BinhAges Up to 2 years - NCT05718726Recruiting
Study of infections after spleen removal surgery
This trial looks at what happens after surgery to remove the spleen in people who also have major cancer surgery through the belly. It may help reduce or better manage serious infections after this kind of operation.
Basingstoke, HampshireAges 18–79 - NCT05902221RecruitingPhase 3
Rifampicin add-on for knee, hip, or shoulder implant infections
This Phase 3 trial tests whether adding rifampicin improves outcomes for implant infections caused by a specific germ (Cutibacterium acnes) after surgery. If you have such an infection and the germ is susceptible, you may be able to receive a rifampicin-based treatment plan.
AnnecyAges 18 years+ - NCT05734391Enrolling by invitation
Tracking hospital infections and germs from nose and rectum swabs
This trial monitors healthcare-associated infections and antibiotic resistance by collecting swabs from the nose and rectum while you are hospitalized. It may help doctors better understand how often these infections happen and how to prevent them.
Philadelphia, PennsylvaniaAges Any age - NCT05264259Recruiting
Monoclonal antibodies for BK virus infection
This study tests a new treatment using lab-made antibodies to treat BK virus infection. It may help by controlling the virus in adults who already test BK positive.
StrasbourgAges 18 years+ - NCT05550298Recruiting
Study of virus infections after pediatric transplants
This study looks at how respiratory viruses behave and how the body responds in children who are about to receive, or have recently received, a transplant. It may help doctors better diagnose and treat viral infections in transplant patients by studying blood samples and test results.
Birmingham, AlabamaAges Up to 18 years - NCT05143307Enrolling by invitationPhase 1
Follow-up study for adults who received EBT-101 for HIV
This study checks how adults are doing long-term after receiving an HIV treatment called EBT-101 in an earlier study. It helps researchers understand safety and longer-term effects over time.
San Francisco, CaliforniaAges 18 years+ - NCT05159739Enrolling by invitation
Study of family genetic risk for joint implant infections
This study looks at whether certain families have a higher genetic risk for infections around joint implants. It may help researchers understand who is more at risk and how to prevent these infections.
Salt Lake City, UtahAges 18–100 - NCT05247112Recruiting
Tracking antibiotic resistance in H. pylori infections in Korea
This study looks at how resistant H. pylori (a stomach germ) is to different antibiotics in Korea. It uses stomach endoscopy samples to test which antibiotics may or may not work, helping guide future treatment choices.
Seongnam-si, Gyeonggi-doAges Any age
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,760 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.